Literature DB >> 27125508

Blue sky and some shadows: new antibiotics and new superbugs : The ECCMID 2016 in Amsterdam.

Johannes R Bogner1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27125508     DOI： 10.1007/s15010-016-0898-7

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

Review 1.  [New antibacterial agents on the market and in the pipeline].

Authors:  W V Kern
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

2.  Occurrence of the Plasmid-Borne mcr-1 Colistin Resistance Gene in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in River Water and Imported Vegetable Samples in Switzerland.

Authors:  Katrin Zurfuh; Laurent Poirel; Patrice Nordmann; Magdalena Nüesch-Inderbinen; Herbert Hächler; Roger Stephan
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

Authors:  Yi-Yun Liu; Yang Wang; Timothy R Walsh; Ling-Xian Yi; Rong Zhang; James Spencer; Yohei Doi; Guobao Tian; Baolei Dong; Xianhui Huang; Lin-Feng Yu; Danxia Gu; Hongwei Ren; Xiaojie Chen; Luchao Lv; Dandan He; Hongwei Zhou; Zisen Liang; Jian-Hua Liu; Jianzhong Shen
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

Review 4.  Novel antibiotics: are we still in the pre-post-antibiotic era?

Authors:  R Draenert; U Seybold; E Grützner; J R Bogner
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

5.  Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.

Authors:  W R Heizmann; P-A Löschmann; C Eckmann; C von Eiff; K-F Bodmann; C Petrik
Journal:  Infection       Date:  2014-11-04       Impact factor: 3.553
  5 in total
  1 in total

1.  Scaring and encouraging news on diagnosis, spreading, and therapy of resistant organisms: the ECCMID 2017 in Vienna.

Authors:  Johannes R Bogner
Journal:  Infection       Date:  2017-06       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.